| Latest Forum Topics / Clearbridge Last:0.002 -- |
 Post Reply
|
|
Medical Stock - Strong Shareholders
|
|||||
|
tccroy
Elite |
11-Dec-2023 09:13
|
||||
|
x 0
x 0 Alert Admin |
Agreed with you. I heard test kit for covid has run out of stock. They are in demand now. Last high was 16.5 cent during pandemic
|
||||
| Useful To Me Not Useful To Me | |||||
|
shk363
Elite |
04-Dec-2023 09:34
|
||||
|
x 0
x 0 Alert Admin |
Pandemic restarting and art kits oos everywhere, share price is v cheap
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
For_The_Next_Leg
Master |
24-Nov-2023 08:58
|
||||
|
x 0
x 0 Alert Admin |
$Clearbridge(1H3.SI) Seems like a turnaround is gonna happen.
https://www.businesstimes.com.sg/companies-markets/clearbridge-mulls-biolidics-request-more-time-repay-s21-million-debt
|
||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
23-Nov-2023 09:40
|
||||
|
x 0
x 0 Alert Admin |
Clearbridge mulls Biolidics&rsquo request for more time to repay S$2.1 million debt
CLEARBRIDGE Health is considering Biolidics&rsquo proposal to repay its debt, which amounts to some S$2.1 million, by the extended deadline of Dec 23, 2023.
The medical technology (medtech) company on Wednesday (Nov 22) said it is also considering its options regarding Biolidics&rsquo outstanding debt and will provide further updates in due course.
On Tuesday, Catalist-listed medtech company Biolidics proposed issuing 98.5 million new ordinary shares at S$0.0119 apiece to raise S$1.2 million from Zhu Hua, a China citizen who owns 99.9 per cent of China-based investment management company, Zhenghe Antai Investment Management.
These new subscription shares would represent 17.62 per cent of Biolidics&rsquo current issued share capital, and 14.98 per cent of its enlarged based following completion of the transaction.
Biolidics&rsquo announcement comes after its earlier proposal to raise S$1.5 million from Zhu, by issuing 230.8 million new shares at S$0.0065 per share, fell through at its Nov 21 extraordinary general meeting (EGM).
Only 40.88 per cent of total shareholders who voted were in favour of the deal, while the remaining 59.12 per cent of shareholders voted against it.
At S$0.0065 per new share, the then-proposed subscription price represented a discount of 56.38 per cent to the volume weighted average price (VWAP) of Biolidics for trades done on Oct 12, 2023, being the date of the subscription agreement.
In a Nov 21 filing, Biolidics said it previously intended to fully utilise net proceeds of about S$1.4 million to partially repay its debt to Clearbridge no later than Nov 25.
As approval for the company&rsquo s earlier subscription agreement was not obtained at the EGM, Biolidics has written to Clearbridge to request for an extension of time to clear its outstanding debt.
Under Biolidics&rsquo most recent proposed new share issuance, its latest price of $0.0119 apiece represents a discount of about 9.85 per cent discount to its VWAP as at Nov 20, 2023 &ndash the last full market day which its shares were traded before the date of the new subscription agreement.
New shares under its latest proposal will be issued under a general mandate which Biolidics obtained from its shareholders at its Apr 28 annual general meeting this year, and will therefore not require the approval of its shareholders.
Biolidics also said completion of its new proposed subscription will not require consent from Clearbridge for its requested outstanding debt extension.
Following completion of the new proposed subscription, Zhu intends to undertake a strategic review of Biolidics and recommend new businesses to the company&rsquo s board where appropriate.
He has also committed to providing financial support to Biolidics through interest-free shareholder&rsquo s loans to ensure that Biolidics will continue to operate as a going concern.
|
||||
| Useful To Me Not Useful To Me | |||||
|
wehuattogether88
Supreme |
22-Nov-2023 16:45
|
||||
|
x 0
x 0 Alert Admin |
Extracted from SGX announcement: OUTSTANDING DEBT FROM BIOLIDICS The Company wishes to announce that it has, on 21 November 2023, received a letter from Biolidics stating that it has negotiated for and finalised plans for an alternative source of funding to repay the Outstanding Debt (&ldquo Alternative Funding&rdquo ), which the Company now understands to be the New Subscription Agreement. Biolidics has therefore requested for an extension of time for the repayment of the Outstanding Debt to 23 December 2023 (&ldquo Proposal&rdquo ). This is also set out in the New Subscription Announcement. The Company is considering the Proposal and considering its options with respect to the Outstanding Debt. The Company will provide further updates through its announcements in due course. As at the date of this announcement, save for Mr Chen Johnson, the Non-Executive and NonIndependent Chairman of the Company, who owns 0.49% of Biolidics, none of the Directors has any interest, direct or indirect, in any matters set out in this announcement, other than through their respective shareholdings in the Company. As at the date of this announcement, based on publicly available information and as far as the Directors are aware, the controlling shareholders of the Company do not have any interest, direct or indirect, in any matters set out in this announcement, other than through their respective shareholdings in the Company. Shareholders and potential investors are reminded to exercise caution when dealing in the securities of the Company and should consult their stockbrokers, bank managers, solicitors, accountants, or other professional advisers if they are in doubt about the actions that they should take. |
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
shk363
Elite |
22-Nov-2023 15:57
|
||||
|
x 0
x 0 Alert Admin |
Halted. Game over? | ||||
| Useful To Me Not Useful To Me | |||||
|
shk363
Elite |
17-Nov-2023 09:00
|
||||
|
x 0
x 0 Alert Admin |
Going below 10 | ||||
| Useful To Me Not Useful To Me | |||||
|
For_The_Next_Leg
Master |
17-Nov-2023 08:55
|
||||
|
x 0
x 0 Alert Admin |
$Clearbridge(1H3.SI) The company is executing a turnaround!
https://links.sgx.com/1.0.0/corporate-announcements/8WGTQU47N12WXBC7/42cdcba70e716a00fdd2579af4919d70ca5e8e3e7519e2c6494b6eeb50ea1cf8
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
shk363
Elite |
08-Nov-2023 08:11
|
||||
|
x 0
x 0 Alert Admin |
Back to 14 today | ||||
| Useful To Me Not Useful To Me | |||||
|
tofudidi
Supreme |
07-Nov-2023 16:03
|
||||
|
x 0
x 0 Alert Admin |
many scoop 16? got chance bb play up this time? | ||||
| Useful To Me Not Useful To Me | |||||
|
wehuattogether88
Supreme |
07-Nov-2023 15:17
|
||||
|
x 0
x 0 Alert Admin |
Yeah, looks like a pump and dump pattern. The stock will not move much. | ||||
| Useful To Me Not Useful To Me | |||||
|
tofudidi
Supreme |
07-Nov-2023 14:51
|
||||
|
x 0
x 0 Alert Admin |
already bottom out. easy rebound like JT..
|
||||
| Useful To Me Not Useful To Me | |||||
|
|
|||||
|
shk363
Elite |
07-Nov-2023 14:40
|
||||
|
x 0
x 0 Alert Admin |
Pump and dump soon? | ||||
| Useful To Me Not Useful To Me | |||||
|
tofudidi
Supreme |
07-Nov-2023 14:22
|
||||
|
x 0
x 0 Alert Admin |
clear 17 soon?
|
||||
| Useful To Me Not Useful To Me | |||||
|
shk363
Elite |
07-Nov-2023 09:19
|
||||
|
x 0
x 0 Alert Admin |
Back to $1 | ||||
| Useful To Me Not Useful To Me | |||||
|
tofudidi
Supreme |
07-Nov-2023 09:17
|
||||
|
x 0
x 0 Alert Admin |
Next penny to go up? Break 20 go 23! | ||||
| Useful To Me Not Useful To Me | |||||
|
Joelton
Supreme |
30-Sep-2023 11:42
|
||||
|
x 0
x 0 Alert Admin |
Lawsuit against Clearbridge CEO, former unit in Jakarta withdrawn
A CIVIL lawsuit in Indonesia against Clearbridge Health : 1H3 +10.53% chief executive Jeremy Yee and the company&rsquo s former subsidiary Indo Genesis Medika (IGM) has been withdrawn.
The lawsuit, filed by a shareholder of IGM, was revoked and withdrawn on Sep 25 at the South Jakarta District Court, Clearbridge said in a Friday (Sep 29) bourse filing. This was with immediate effect.
The plaintiff was Kreasi Putra Nusantara (KPN), an Indonesian biotechnology company. The court summons were related to an extraordinary general meeting (EGM) of IGM held on Dec 12, 2022, as well as an invitation sent to effect the EGM, The Business Times previously reported.
However, KPN withdrew the suit before the court examined the matter, Clearbridge said in its Friday update. KPN was ordered to pay a court administration fee of 2.7 million rupiah (S$235.32).
|
||||
| Useful To Me Not Useful To Me | |||||
|
shk363
Elite |
13-Sep-2023 19:04
|
||||
|
x 0
x 0 Alert Admin |
Ya. Stuck at above 20 for a while. Restarting to go below 10 soon.
|
||||
| Useful To Me Not Useful To Me | |||||
|
For_The_Next_Leg
Master |
13-Sep-2023 09:38
|
||||
|
x 0
x 0 Alert Admin |
$Clearbridge(1H3.SI) " On 21 July 2023, Clearbridge BSA Pte. Ltd. (&ldquo CBSA&rdquo ), a wholly-owned subsidiary of the Company, entered into an agreement for the sale of 57,123,300 shares it holds in Biolidics Limited (&ldquo Biolidics&rdquo ) (&ldquo Sale Shares&rdquo ), a company listed on SGX Catalist, to an unrelated third party by way of a married deal through SGX-ST (the &ldquo Disposal&rdquo ). The aggregate consideration for the Disposal is S$932,823.49 or S$0.01633 per Sale Share, satisfied in cash and in full on the completion of the Disposal. The Disposal was completed on 21 July 2023 (&ldquo Completion&rdquo ) and upon Completion, the Company no longer holds any shares in Biolidics"
Company is restarting. A bottom is forming.
https://links.sgx.com/1.0.0/corporate-announcements/J14OKWHHCUCBXP68/0de7cd470b7c799fa97e1f99a11c04289508369c6f7268d3187cdd4217119721
|
||||
| Useful To Me Not Useful To Me | |||||
|
For_The_Next_Leg
Master |
10-Aug-2023 11:10
|
||||
|
x 0
x 0 Alert Admin |
$Clearbridge(1H3.SI) Company is transforming into a distributor most probably. The disposal of Biolidics shares will make the transition smoother.
https://links.sgx.com/1.0.0/corporate-announcements/Y4795AQB6Z98RHW4/d99bd9c94f604651fef1967bf69a2f1191cbff3d02cf8a459e40e085e9c6d1ba
|
||||
| Useful To Me Not Useful To Me | |||||